15-72686190-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000566400.6(BBS4):​c.-507C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0662 in 1,549,504 control chromosomes in the GnomAD database, including 3,973 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 239 hom., cov: 32)
Exomes 𝑓: 0.068 ( 3734 hom. )

Consequence

BBS4
ENST00000566400.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.77

Publications

19 publications found
Variant links:
Genes affected
BBS4 (HGNC:969): (Bardet-Biedl syndrome 4) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein "BBSome" complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
HIGD2B (HGNC:26984): (HIG1 hypoxia inducible domain family member 2B) Predicted to be involved in mitochondrial respirasome assembly. Predicted to be integral component of membrane. Predicted to be active in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-72686190-C-A is Benign according to our data. Variant chr15-72686190-C-A is described in ClinVar as Benign. ClinVar VariationId is 262133.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0712 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS4NM_033028.5 linkc.-38C>A upstream_gene_variant ENST00000268057.9 NP_149017.2
HIGD2BNM_001350932.3 linkc.-565G>T upstream_gene_variant ENST00000311755.6 NP_001337861.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS4ENST00000268057.9 linkc.-38C>A upstream_gene_variant 1 NM_033028.5 ENSP00000268057.4
HIGD2BENST00000311755.6 linkc.-565G>T upstream_gene_variant 1 NM_001350932.3 ENSP00000307951.3

Frequencies

GnomAD3 genomes
AF:
0.0471
AC:
7164
AN:
152216
Hom.:
239
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0144
Gnomad AMI
AF:
0.0921
Gnomad AMR
AF:
0.0376
Gnomad ASJ
AF:
0.0199
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0211
Gnomad FIN
AF:
0.0634
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0729
Gnomad OTH
AF:
0.0488
GnomAD2 exomes
AF:
0.0458
AC:
7214
AN:
157460
AF XY:
0.0453
show subpopulations
Gnomad AFR exome
AF:
0.00973
Gnomad AMR exome
AF:
0.0352
Gnomad ASJ exome
AF:
0.0235
Gnomad EAS exome
AF:
0.0000851
Gnomad FIN exome
AF:
0.0606
Gnomad NFE exome
AF:
0.0725
Gnomad OTH exome
AF:
0.0465
GnomAD4 exome
AF:
0.0683
AC:
95471
AN:
1397170
Hom.:
3734
Cov.:
30
AF XY:
0.0672
AC XY:
46327
AN XY:
689498
show subpopulations
African (AFR)
AF:
0.00979
AC:
311
AN:
31762
American (AMR)
AF:
0.0360
AC:
1295
AN:
36016
Ashkenazi Jewish (ASJ)
AF:
0.0215
AC:
543
AN:
25202
East Asian (EAS)
AF:
0.000111
AC:
4
AN:
36054
South Asian (SAS)
AF:
0.0217
AC:
1718
AN:
79276
European-Finnish (FIN)
AF:
0.0584
AC:
2767
AN:
47354
Middle Eastern (MID)
AF:
0.00773
AC:
32
AN:
4142
European-Non Finnish (NFE)
AF:
0.0794
AC:
85665
AN:
1079472
Other (OTH)
AF:
0.0542
AC:
3136
AN:
57892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
5055
10111
15166
20222
25277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3200
6400
9600
12800
16000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0470
AC:
7163
AN:
152334
Hom.:
239
Cov.:
32
AF XY:
0.0453
AC XY:
3378
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0144
AC:
599
AN:
41584
American (AMR)
AF:
0.0375
AC:
573
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
69
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.0211
AC:
102
AN:
4830
European-Finnish (FIN)
AF:
0.0634
AC:
674
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0729
AC:
4956
AN:
68020
Other (OTH)
AF:
0.0478
AC:
101
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
363
725
1088
1450
1813
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0646
Hom.:
532
Bravo
AF:
0.0438
Asia WGS
AF:
0.00779
AC:
28
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Bardet-Biedl syndrome 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.030
DANN
Benign
0.86
PhyloP100
-2.8
PromoterAI
0.30
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11637927; hg19: chr15-72978531; API